Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Franklin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Transfusion Medicine (Oxford, England)|June 15, 2007
Is there a right to donate blood? Patient rights; donor responsibilitiesIan M Franklin
Leukemia & Lymphoma|December 5, 2008
Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapySimon J Harrison, Ian M Franklin, John D M Campbell
British Journal of Haematology|May 25, 2002
Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatmentAndrew D Clark, Kenneth W Douglas, Lyndsay D Mitchell, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Blood|December 1, 2007
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H Goldstone, Susan M Richards, Hillard M Lazarus, et al.
Blood|February 27, 2009
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993Adele K Fielding, Jacob M Rowe, Susan M Richards, et al.
British Journal of Haematology|May 19, 2004
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J Harrison, Anthony V Moorman, Zoë J Broadfield, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Transfusion Medicine (Oxford, England)|June 15, 2007
Is there a right to donate blood? Patient rights; donor responsibilitiesIan M Franklin
Leukemia & Lymphoma|December 5, 2008
Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapySimon J Harrison, Ian M Franklin, John D M Campbell
British Journal of Haematology|May 25, 2002
Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatmentAndrew D Clark, Kenneth W Douglas, Lyndsay D Mitchell, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Blood|December 1, 2007
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H Goldstone, Susan M Richards, Hillard M Lazarus, et al.
Blood|February 27, 2009
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993Adele K Fielding, Jacob M Rowe, Susan M Richards, et al.
British Journal of Haematology|May 19, 2004
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J Harrison, Anthony V Moorman, Zoë J Broadfield, et al.
Pageof 1